Globus Medical (GMED) Change in Accured Expenses (2011 - 2026)

Globus Medical (GMED) has reported Change in Accured Expenses for 16 consecutive years, with -$11.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Change in Accured Expenses fell 174.71% year-over-year to -$11.1 million; the trailing twelve-month figure through Jun 2026 stood at $12.3 million (down 38.81% YoY), and the FY2025 full-year result was $34.2 million, up 581.21% from the prior year.
• Change in Accured Expenses improved to -$11.1 million in Q2 2026 per GMED's latest filing, from -$24.7 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $39.3 million in Q3 2025 and bottomed at -$33.9 million in Q1 2024.
• Historically, Change in Accured Expenses has averaged $1.5 million across 5 years, with a median of $4.8 million in 2024.
• The widest YoY moves for Change in Accured Expenses: up 234.24% in 2024, down 239.86% in 2024.
• Over 5 years, Change in Accured Expenses stood at $4.4 million in 2022, then tumbled by 177.98% to -$3.5 million in 2023, then surged by 234.24% to $4.6 million in 2024, then soared by 89.36% to $8.8 million in 2025, then slumped by 226.15% to -$11.1 million in 2026.
• According to Business Quant data, Change in Accured Expenses over the past three periods registered -$11.1 million, -$24.7 million, and $8.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.